Supernus: Q3 Earnings Snapshot
By AP News
Published - Nov 04, 2024, 06:33 PM ET
Last Updated - Dec 16, 2024, 05:41 PM EST
ROCKVILLE, Md. (AP) — ROCKVILLE, Md. (AP) — Supernus Pharmaceuticals Inc. (SUPN) on Monday reported profit of $38.5 million in its third quarter.
The Rockville, Maryland-based company said it had net income of 69 cents per share. Earnings, adjusted for one-time gains and costs, came to $1.06 per share.
The drugmaker posted revenue of $175.7 million in the period, surpassing Street forecasts. Three analysts surveyed by Zacks expected $155.1 million.
Supernus expects full-year revenue in the range of $630 million to $650 million.